Verde Bio Holdings annual ebitda
2012
2013
2014
2020
2021
2022
Verde Bio Holdings's calculated EBITDA was −$3.1M for fiscal 2022.
View full Verde Bio Holdings company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-04-30 | −$3.1M | −$158,173 | — |
| 2021 | 2021-04-30 | −$3.0M | −$2.7M | — |
| 2020 | 2020-04-30 | −$259,217 | −$124,983 | — |
| 2014 | 2014-04-30 | −$134,234 | $26,160 | — |
| 2013 | 2013-04-30 | −$160,394 | −$9,498 | — |
| 2012 | 2012-04-30 | −$150,896 | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2024 | 2023-10-31 | −$287,844 | $369,609 | — |
| Q1 2024 | 2023-07-31 | −$224,014 | $284,219 | — |
| Q3 2023 | 2023-01-31 | −$399,394 | $39,933 | — |
| Q2 2023 | 2022-10-31 | −$109,793 | $1.4M | — |
| Q1 2023 | 2022-07-31 | −$657,453 | −$2,092 | — |
| Q4 2022 | 2022-04-30 | −$508,233 | $1.9M | — |
| Q3 2022 | 2022-01-31 | −$439,327 | −$338,469 | — |
| Q2 2022 | 2021-10-31 | −$1.5M | −$1.4M | — |
| Q1 2022 | 2021-07-31 | −$655,361 | −$313,799 | — |
| Q4 2021 | 2021-04-30 | −$2.4M | −$2.4M | — |
| Q3 2021 | 2021-01-31 | −$100,858 | −$88,351 | — |
| Q2 2021 | 2020-10-31 | −$97,653 | −$65,926 | — |
| Q1 2021 | 2020-07-31 | −$341,562 | −$284,099 | — |
| Q4 2014 | 2014-04-30 | −$32,537 | $42,128 | — |
| Q3 2014 | 2014-01-31 | −$12,507 | $46,637 | — |
| Q2 2014 | 2013-10-31 | −$31,727 | −$18,479 | — |
| Q1 2014 | 2013-07-31 | −$57,463 | −$44,126 | — |
| Q4 2013 | 2013-04-30 | −$74,665 | −$32,383 | — |
| Q3 2013 | 2013-01-31 | −$59,144 | −$1,130 | — |
| Q2 2013 | 2012-10-31 | −$13,248 | $7,153 | — |
| Q1 2013 | 2012-07-31 | −$13,337 | $16,862 | — |
| Q4 2012 | 2012-04-30 | −$42,282 | −$12,659 | — |
| Q3 2012 | 2012-01-31 | −$58,014 | — | — |
| Q2 2012 | 2011-10-31 | −$20,401 | — | — |
| Q1 2012 | 2011-07-31 | −$30,199 | — | — |
| Q1 2011 | 2010-07-31 | −$29,623 | — | — |
Over the last five reported fiscal years, Verde Bio Holdings's ebitda decreased from −$150,896 to −$3.1M, a change of −$3.0M. The latest reported quarter, Q2 2024, shows −$287,844.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Verde Bio Holdings filings at SEC.gov ↗